In summary, our findings reveal a significantly elevated peripheral gene expression of SNCA, GBA1, and UGCG among patients currently experiencing depression which partially normalizes for GBA1 and UGCG in the group of medicated patients and also reflects increased depression severity in subgroups. The gene discussed is GBA1; the disease is depressive symptom measurement.